Clinical Trial
Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report
- PMID: 376134
Item in Clipboard
Clinical Trial
Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report
Cancer Treat Rep.
1979 Feb.
No abstract available
Similar articles
-
Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1745-53. Cancer Treat Rep. 1979. PMID: 393378 Clinical Trial. No abstract available.
-
Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.Cancer Treat Rep. 1979 Feb;63(2):307-9. Cancer Treat Rep. 1979. PMID: 109201
-
Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.Cancer Treat Rep. 1978 Jul;62(7):1021-3. Cancer Treat Rep. 1978. PMID: 688244
-
cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1539-44. Cancer Treat Rep. 1979. PMID: 387224 Review.
-
Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. doi: 10.1006/gyno.1994.1347. Gynecol Oncol. 1994. PMID: 7835816 Review.
Cited by
-
Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.J Clin Invest. 1986 Feb;77(2):545-50. doi: 10.1172/JCI112335. J Clin Invest. 1986. PMID: 3944268 Free PMC article.
-
Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.J Natl Med Assoc. 1988 May;80(5):565-76. J Natl Med Assoc. 1988. PMID: 3047411 Free PMC article. Review.
-
cis-Platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma.Cancer Chemother Pharmacol. 1983;10(2):100-3. doi: 10.1007/BF00446218. Cancer Chemother Pharmacol. 1983. PMID: 6403254 Clinical Trial.
-
Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.Can Med Assoc J. 1980 Sep 6;123(5):365-71. Can Med Assoc J. 1980. PMID: 7020903 Free PMC article. Clinical Trial.
-
Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.Cochrane Database Syst Rev. 2016 Mar 3;3(3):CD005008. doi: 10.1002/14651858.CD005008.pub4. Cochrane Database Syst Rev. 2016. PMID: 26938118 Free PMC article.